Sharescart Research Club logo ×
Screener Research Unlisted Startup Funding New IPO New

Join Channel
Consolidated Standalone

MK Proteins

₹11.1 0.2 | 1.7%

Market Cap ₹415 Cr.

Stock P/E 77.0

P/B 5.1

Current Price ₹11.1

Book Value ₹ 2.1

Face Value 1

52W High ₹33.3

Dividend Yield 0%

52W Low ₹ 9.6

Edit Ratio

MK Proteins Research see more...

Overview Inc. Year: 2012Industry: Edible Oil

MK Proteins Ltd is a food manufacturing company based in India. Established in 1996, the company specializes in the production of soybean meal, which is used as animal feed. MK Proteins has a strong presence in the domestic and international markets, with a focus on Asia, Europe, and the Middle East. The company's state-of-the-art manufacturing facilities are located in Madhya Pradesh, India, and are equipped with modern machinery and technology to ensure high-quality products. MK Proteins is committed to sustainability and ethical business practices, and the company's soybean meal is made from non-genetically modified soybeans. With a dedicated team of professionals and a focus on innovation and customer satisfaction, MK Proteins is poised for continued growth and success in the global food industry.

Read More..

MK Proteins Share Price

New

₹ | |

Volume
Price

Quarterly Price

Quarterly Monthly
Show Value Show %

Peer Comparison

MK Proteins Quarterly Results

#(Fig in Cr.) Jun 2023 Sep 2023 Dec 2023
Net Sales 76 14 69
Other Income 0 0 0
Total Income 76 14 69
Total Expenditure 72 13 65
Operating Profit 4 1 4
Interest 1 0 0
Depreciation 0 0 0
Exceptional Income / Expenses 0 0 0
Profit Before Tax 3 1 3
Provision for Tax 1 0 1
Profit After Tax 2 0 2
Adjustments -0 -0 0
Profit After Adjustments 2 0 2
Adjusted Earnings Per Share 0.1 0 0.1

MK Proteins Profit & Loss

#(Fig in Cr.) Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
Net Sales 85 122 123 145 165 172 157 194 311 256 315 159
Other Income 0 0 0 0 0 0 0 0 0 0 0 0
Total Income 85 122 123 145 165 172 157 194 311 256 315 159
Total Expenditure 84 119 119 141 160 166 152 189 295 240 298 150
Operating Profit 2 3 4 4 5 6 5 5 16 16 17 9
Interest 1 2 2 2 2 2 2 2 1 1 2 1
Depreciation 0 0 1 1 1 1 1 1 1 1 1 0
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 1 1 1 1 2 2 2 2 14 14 15 7
Provision for Tax 0 0 0 0 1 1 1 1 4 4 4 2
Profit After Tax 1 0 1 1 1 1 2 2 10 10 11 4
Adjustments 0 0 0 0 0 0 0 0 0 0 0 0
Profit After Adjustments 1 0 1 1 1 1 2 2 10 10 11 4
Adjusted Earnings Per Share 0 0 0 0 0 0 0 0 0.3 0.3 0.3 0.2

Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR 23% 18% 13% 14%
Operating Profit CAGR 6% 50% 23% 24%
PAT CAGR 10% 77% 62% 27%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR -57% -48% 71% NA%
ROE Average 24% 32% 23% 27%
ROCE Average 19% 24% 18% 14%

MK Proteins Balance Sheet

#(Fig in Cr.) Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Shareholder's Funds 1 2 3 3 4 15 17 19 29 40 50
Minority's Interest 0 0 0 0 0 0 0 0 0 0 0
Borrowings 5 10 7 8 12 12 2 4 4 3 3
Other Non-Current Liabilities 0 0 0 0 0 0 -0 -0 -0 -0 -0
Total Current Liabilities 15 20 25 28 30 29 29 34 34 44 52
Total Liabilities 21 32 35 39 47 56 47 56 67 86 105
Fixed Assets 3 3 6 7 7 6 4 3 2 3 2
Other Non-Current Assets 1 4 0 0 0 0 0 0 0 0 0
Total Current Assets 17 26 29 32 39 50 42 53 64 82 102
Total Assets 21 32 35 39 47 56 47 56 67 86 105

MK Proteins Cash Flow

#(Fig in Cr.) Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Opening Cash & Cash Equivalents 0 0 0 0 0 0 0 0 0 0 0
Cash Flow from Operating Activities -14 -5 11 -4 -4 -12 6 -4 6 -10 -8
Cash Flow from Investing Activities -4 -3 -0 -2 -1 -0 0 0 -0 -2 0
Cash Flow from Financing Activities 18 8 -10 6 5 12 -7 4 -5 12 8
Net Cash Inflow / Outflow 0 -0 -0 0 -0 0 -0 0 -0 0 0
Closing Cash & Cash Equivalent 0 0 0 0 0 0 0 0 0 0 0

MK Proteins Ratios

# Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Earnings Per Share (Rs) 0.02 0.02 0.03 0.03 0.04 0.04 0.04 0.05 0.28 0.27 0.28
CEPS(Rs) 0.03 0.03 0.06 0.07 0.09 0.07 0.08 0.08 0.3 0.3 0.3
DPS(Rs) 0 0 0 0 0 0 0 0 0 0 0
Book NAV/Share(Rs) 0.05 0.07 0.1 0.13 0.16 0.41 0.46 0.5 0.78 1.06 1.34
Core EBITDA Margin(%) 1.9 2.3 3.38 2.92 3 3.21 3.2 2.48 5.14 6.06 5.38
EBIT Margin(%) 1.64 2.02 2.84 2.33 2.3 2.56 2.46 2.04 4.87 5.83 5.21
Pre Tax Margin(%) 0.92 0.6 0.99 0.72 0.92 1.28 1.46 1.26 4.6 5.49 4.64
PAT Margin (%) 0.62 0.4 0.68 0.5 0.6 0.83 1.05 0.94 3.34 3.98 3.38
Cash Profit Margin (%) 0.89 0.7 1.22 1.12 1.33 1.54 1.83 1.54 3.63 4.34 3.62
ROA(%) 2.49 1.85 2.48 1.94 2.3 2.78 3.18 3.51 16.83 13.32 11.18
ROE(%) 43.99 33.94 39.43 24.9 27.1 14.62 10.07 10.07 43.03 29.54 23.69
ROCE(%) 7.23 10.06 13.53 13.06 11.82 10.57 8.42 8.54 29.13 22.82 19.15
Receivable days 31.48 20.34 17.24 20.25 16.87 24.54 34.18 19.13 17.69 35.56 26.44
Inventory Days 37.19 41.27 60.14 52.77 59.12 67.28 69.12 64.25 44.99 62.38 70.12
Payable days 6.34 5.11 22.28 27.84 21.28 16.85 9.8 6.29 7.51 10.5 6.29
PER(x) 0 0 0 0 0 23.49 18.9 16.39 3.19 7.84 0
Price/Book(x) 0 0 0 0 0 2.16 1.81 1.57 1.13 2.02 0
Dividend Yield(%) 0 0 0 0 0 0 0 0 0 0 0
EV/Net Sales(x) 0.22 0.23 0.17 0.18 0.2 0.39 0.37 0.31 0.19 0.46 0.18
EV/Core EBITDA(x) 11.32 10.1 4.87 6.19 6.68 11.78 11.25 11.73 3.63 7.36 3.32
Net Sales Growth(%) 0 42.54 1.23 17.46 13.67 4.32 -8.66 23.82 60.26 -17.75 23.05
EBIT Growth(%) 0 76.16 42.3 -3.81 12.51 15.91 -12.24 2.61 282.21 -1.43 9.8
PAT Growth(%) 0 -7.09 69.26 -13.67 36.54 44.67 15.18 10.57 471.79 -1.97 4.53
EPS Growth(%) 0 -6.88 68.97 -13.7 36.49 -5.94 15.26 10.5 471.9 -1.99 4.53
Debt/Equity(x) 15.02 16.4 7.76 8.03 7.66 2.13 1.53 1.61 0.86 0.93 0.89
Current Ratio(x) 1.15 1.26 1.14 1.15 1.3 1.73 1.48 1.57 1.92 1.88 1.96
Quick Ratio(x) 0.57 0.33 0.28 0.42 0.19 0.69 0.46 0.41 0.79 0.74 0.59
Interest Cover(x) 2.28 1.42 1.54 1.45 1.66 2 2.45 2.61 18.37 16.82 9.16
Total Debt/Mcap(x) 0 0 0 0 0 0.98 0.84 1.03 0.76 0.46 0

MK Proteins Shareholding Pattern

# Sep 2020 Mar 2021 Sep 2021 Mar 2022 Sep 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024
Promoter 74.82 74.82 74.82 74.82 74.82 74.82 74.82 74.82 74.82 74.82
FII 0 0 0 0 0 0 0 0 0 0.02
DII 0 0 0 0 0 0 0 0 0 0
Public 25.18 25.18 25.18 25.18 25.18 25.18 25.18 25.17 25.18 25.16
Others 0 0 0 0 0 0 0 0 0 0
Total 100 100 100 100 100 100 100 100 100 100

Pros

  • Company has delivered good profit growth of 61% CAGR over last 5 years
  • Company has a good return on equity (ROE) track record: 3 Years ROE 32%
  • Debtor days have improved from 10.5 to 6.29days.

Cons

  • Stock is trading at 5.1 times its book value.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

MK Proteins News

IPO

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

You May Also Know About

Unlisted Shares Pre-IPO Shares ESOP Shares Delisted Shares

Please Login!

Click to Login
OR
Get free Account

Error!